Common Contracts
7 similar Underwriting Agreement contracts by iBio, Inc., Addentax Group Corp., Alset Inc., others
UNDERWRITING AGREEMENTUnderwriting Agreement • May 5th, 2023 • Modular Medical, Inc. • Surgical & medical instruments & apparatus • New York
The undersigned, Modular Medical, Inc., a corporation formed under the laws of the State of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with Newbridge Securities Corporation (hereinafter referred to as “you” or the “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2023 • Alset Inc. • Real estate • New York
The undersigned, Alset Inc., a Texas corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • January 22nd, 2021 • Addentax Group Corp. • Services-mailing, reproduction, commercial art & photography • New York
The undersigned, Addentax Group Corp., a corporation formed under the laws of the State of Nevada (the “Company”), hereby confirms its agreement (this “Agreement”) with Network 1 Financial Securities, Inc. (hereinafter the “Underwriter”) as follows:
UNDERWRITING AGREEMENTUnderwriting Agreement • August 3rd, 2018 • PeerStream, Inc. • Services-business services, nec • New York
GENPREX, INC. AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • December 12th, 2017 • Genprex, Inc. • Pharmaceutical preparations • New York
Genprex, Inc., a corporation organized and existing under the laws of State of Delaware (the “Company”), agrees, subject to the terms and conditions of this agreement (this “Agreement”) to issue and sell to Network 1 Financial Securities, Inc. (“Network 1” or the “Underwriter”) an aggregate of one million three hundred thousand (1,300,000) shares of common stock (the “Firm Shares”), par value $0.001 per share, of the Company (the “Common Stock”). At the option of the Underwriter, the Company agrees, subject to the terms and conditions herein, to issue and sell up to an aggregate of 195,000 additional shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are herein referred to collectively as the “Securities”.
AMENDED AND RESTATED UNDERWRITING AGREEMENT between iBio, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters November 30, 2017Underwriting Agreement • December 1st, 2017 • iBio, Inc. • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENT between iBio, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters November 29, 2017Underwriting Agreement • November 29th, 2017 • iBio, Inc. • Pharmaceutical preparations • New York
